Hospitalist Doctors in Texas Medicare Details, Address, Contact

769 Hospitalist doctors found. Showing 201 - 220

Nadear A Elmahi, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 12221 Merit Dr, Ste 1500, Dallas, TX 75251 Phone: 214-217-1900    Fax: 214-217-1912

Devadatta Sarwate, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 12221 Merit Dr, Suite 1500, Dallas, TX 75251 Phone: 972-832-7053

Mrs. Farihah Badar Perwez, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 5323 Harry Hines Blvd, Dallas, TX 75390 Phone: 214-648-9741    Fax: 214-648-9531

Dr. Denny Poikayil Jacob, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 5200 Harry Hines Blvd, Dallas, TX 75390 Phone: 214-648-9741

Tiffany Y Lee, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 6201 Harry Hines Blvd, Dallas, TX 75390 Phone: 214-633-5555

Dr. Jeffrey Earl Levea, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 5323 Harry Hines Blvd, Dallas, TX 75390 Phone: 214-633-5555

Antonia Plamenova Dalton, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 5323 Harry Hines Blvd, Dallas, TX 75390 Phone: 214-648-3111

James R Goodsett, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1441 N Beckley Ave, Dallas, TX 75203 Phone: 214-947-2389    Fax: 214-947-2390

Eric Chang, Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 5323 Harry Hines Blvd, Dallas, TX 75390 Phone: 214-590-8000

Samuel Eleanya, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 3500 W Wheatland Rd, Dallas, TX 75237 Phone: 219-669-0700

Graham Reed Ellington, Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 6201 Harry Hines Blvd, Dallas, TX 75390 Phone: 214-633-5555

Dr. Pramod Pinnamaneni, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 5201 Harry Hines Blvd, Graduate Medical Education, Dallas, TX 75235 Phone: 214-590-8058

Dr. Chinelo Uche, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 3500 W Wheatland Rd, Dallas, TX 75237 Phone: 214-947-7777

Sudha Thangam Somasundaravelayudham, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 5323 Harry Hines Blvd, Dallas, TX 75390 Phone: 214-648-9741    Fax: 214-648-9531

Camli Al-sadek, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 6201 Harry Hines Blvd, Dallas, TX 75390 Phone: 214-633-5555

Dr. Libay F Woldeyes, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 5323 Harry Hines Blvd, Dallas, TX 75390 Phone: 214-648-9741    Fax: 214-648-9531

Omer Mirza, Hospitalist Medicare: Medicare Enrolled Practice Location: 221 W Colorado Blvd Ste 525, Dallas, TX 75208 Phone: 214-960-5681

Lindsey Fowler, PA-C Hospitalist Medicare: Medicare Enrolled Practice Location: 5200 Harry Hines Blvd, Dallas, TX 75235 Phone: 214-590-8000

Dr. Rahim Mamud Dhanani, MD, MS Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 3500 Gaston Ave, Dallas, TX 75246 Phone: 214-820-0111

Aysha Kunju, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 3600 Gaston Ave, Suite 550, Dallas, TX 75246 Phone: 214-821-8867    Fax: 214-821-1193

News Archive

CryoLife files PerClot IDE with FDA to initiate clinical trials in the U.S.

CryoLife, Inc., an implantable biological medical device and cardiovascular tissue processing company, announced today that it has filed an IDE with the United States Food and Drug Administration to begin clinical trials for the purpose of obtaining Pre-Market Approval to distribute PerClot in the U.S. to control bleeding during surgical procedures or following traumatic injuries.

Green Cross' Biologics License Application for IVIG-SN submitted to FDA

Green Cross Corporation, a South Korean biopharmaceutical company, today announced that it has submitted its Biologics License Application for IVIG-SN (human normal immunoglobulin G for intravenous administration) to the United States Food and Drug Administration.

Greater risk of heart attack associated with Vioxx than Celebrex

In the first epidemiological study designed and executed specifically to determine the heart-attack risk associated with COX-2 inhibitors rofecoxib (Vioxx) and celecoxib (Celebrex), researchers at the University of Pennsylvania School of Medicine found a greater risk of heart attack associated with Vioxx than Celebrex, although neither of the two drugs showed a statistically significant elevated risk of heart attack relative to people who did not use the drugs.

Antibodies produced by people who recovered from H1N1 offer clues for universal flu vaccine

The antibodies produced by individuals who fought off H1N1 (swine flu) infection last year may bring researchers one step closer to their quest to develop a "universal" flu vaccine, U.S. researchers said Monday, HealthDay News/Bloomberg Businessweek reports.

Read more Medical News

› Verified 6 days ago

• «
• 6
• 7
• 8
• 9
• 10
• 11(current)
• 12
• 13
• 14
• 15
• 16
• »